FDA ALERTS
FDA ALERTS
01/27/2023
Following a multicenter study, the FDA approved the combination of albuterol and budesonide—an inhaled corticosteroid—for the treatment of asthma in adults.
01/27/2023
Medication prescribing
Medication prescribing
03/16/2022
A generic drug-product combination for the treatment of asthma and COPD was just approved by the US Food and Drug Administration.
03/16/2022
FDA
FDA
11/14/2018
The American Thoracic Society says the FDA approved the asthma treatment with lack of consideration for patient safety and for a public policy process.
11/14/2018
asthma
asthma
06/28/2018
In 2010, the FDA mandated that 4 companies marketing long-acting β2 agonists perform trials comparing the safety of combination therapy with LABA plus an inhaled glucocorticoid vs an inhaled glucocorticoid...
06/28/2018
asthma
asthma
11/15/2017
The FDA has approved a new add-on maintenance treatment option for patients with severe asthma with eosinophilic phenotype.
11/15/2017
smoking
smoking
07/31/2017
To address growing public health concerns, the US Food and Drug Administration is designing a new plan to serve as a roadmap for regulating tobacco products in the future, in order to reduce smoking...
07/31/2017
asthma
asthma
01/30/2017
The FDA approved Symbicort Inhalation Aerosol 80/4.5 for the treatment for the treatment of asthma in pediatric patients aged 6 to 12 years.
01/30/2017
asthma
asthma
01/30/2017
The FDA has approved AirDuo RespiClick and ArmonAir RespiClick for the treatment of adolescent and adult patients with asthma.
01/30/2017
Asthma
Asthma
05/06/2016
The FDA finalized a rule extending its authority to all tobacco products, including e-cigarettes, cigars, hookah tobacco, and pipe tobacco, among others.
05/06/2016
COPD
COPD
09/18/2015
The FDA has approved a drug already indicated for COPD treatment for the long-term, once-daily maintenance of asthma in individuals 12 years old and older.
09/18/2015